The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,277.00
Bid: 3,278.00
Ask: 3,279.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.031%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3,277.00
EXPN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update, Q2 revenue expectations revised

8 Sep 2020 07:00

RNS Number : 2787Y
Experian plc
08 September 2020
 

news release

 

 

 

Trading update, second quarter revenue expectations revised 

 

8 September 2020, 7am Experian, the global information services company, today issues an update on its expectations for trading for the three months ending 30 September 2020.

 

In July 2020, we stated that we expected organic revenue for Q2 FY21 would be in the range of flat to (5)% and that organic costs for the first half would be held broadly flat.

 

Following stronger trading in July and August, we today revise our Q2 FY21 expectations. We now expect Group organic revenue growth for the quarter to be in the range +3 to +5%, helped by further strength in US mortgage (which we expect will contribute +3 percentage points to growth in Q2), strength in the services we provide to consumers, as well as due to the naturally resilient qualities of parts of our portfolio.

 

With continued investment in our innovation agenda, we now expect organic growth in costs of between 2 and 3% for the first half.

 

Experian will release results for the first half ending 30 September 2020 on Tuesday 17 November 2020.

 

Contact:

Experian

Nadia Ridout-Jamieson Investor queries +44 (0)20 3042 4278

Gerry Tschopp Media queries

 

Finsbury

Rollo Head +44 (0)7768 994 987

Jenny Davey +44 (0)7901 513 610

 

This announcement is available on the Experian website at www.experianplc.com.

 

This announcement contains inside information. All financial information in this trading update is based on unaudited management accounts. Certain statements made in this trading update are forward-looking statements. Such statements are based on current expectations and are subject to a number of risks and uncertainties that could cause actual events or results to differ materially from any expected future events or results referred to in these forward-looking statements.

 

Neither the content of the Company's website, nor the content of any website accessible from hyperlinks on the Company's website (or any other website), is incorporated into, or forms part of, this announcement.

 

About Experian

Experian is the world's leading global information services company. During life's big moments - from buying a home or a car, to sending a child to college, to growing a business by connecting with new customers - we empower consumers and our clients to manage their data with confidence. We help individuals to take financial control and access financial services, businesses to make smarter decisions and thrive, lenders to lend more responsibly, and organisations to prevent identity fraud and crime.

 

We have 17,800 people operating across 45 countries and every day we're investing in new technologies, talented people and innovation to help all our clients maximise every opportunity. We are listed on the London Stock Exchange (EXPN) and are a constituent of the FTSE 100 Index.

 

Learn more at www.experianplc.com or visit our global content hub at our global news blog for the latest news and insights from the Group.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTLRMPTMTIMBAM
Date   Source Headline
30th Apr 20245:24 pmRNSTransaction in Own Shares
30th Apr 202411:22 amRNSTotal Voting Rights
29th Apr 20245:52 pmRNSTransaction in Own Shares
26th Apr 20245:19 pmRNSTransaction in Own Shares
25th Apr 20245:16 pmRNSTransaction in Own Shares
24th Apr 20245:14 pmRNSTransaction in Own Shares
23rd Apr 20245:28 pmRNSTransaction in Own Shares
22nd Apr 20245:34 pmRNSTransaction in Own Shares
19th Apr 20245:42 pmRNSTransaction in Own Shares
18th Apr 20245:41 pmRNSTransaction in Own Shares
17th Apr 20245:21 pmRNSTransaction in Own Shares
16th Apr 20245:40 pmRNSTransaction in Own Shares
15th Apr 20245:39 pmRNSTransaction in Own Shares
12th Apr 20246:00 pmRNSTransaction in Own Shares
11th Apr 20245:42 pmRNSTransaction in Own Shares
10th Apr 20245:44 pmRNSTransaction in Own Shares
10th Apr 20249:45 amRNSAdditional Listing
9th Apr 20246:04 pmRNSTransaction in Own Shares
8th Apr 20246:14 pmRNSTransaction in Own Shares
8th Apr 20247:54 amRNSShare repurchase programme
4th Apr 20246:00 pmRNSExperian to acquire Illion in ANZ
3rd Apr 20249:30 amRNSDirector/PDMR Shareholding
28th Mar 202411:05 amRNSTotal Voting Rights
21st Mar 202412:15 pmRNSBlock listing Interim Review
20th Mar 20248:47 amRNSAdditional Listing
14th Mar 20242:08 pmRNSAdditional Listing
6th Mar 20249:15 amRNSAdditional Listing
4th Mar 202411:45 amRNSExperian signs new Revolving Credit Facility
29th Feb 202411:30 amRNSTotal Voting Rights
28th Feb 202410:15 amRNSDirector/PDMR Shareholding
28th Feb 20249:15 amRNSAdditional Listing
21st Feb 20249:15 amRNSAdditional Listing
14th Feb 20249:15 amRNSAdditional Listing
7th Feb 20249:14 amRNSAdditional Listing
6th Feb 20243:47 pmRNSDirector/PDMR Shareholding
31st Jan 202410:00 amRNSTotal Voting Rights
31st Jan 20249:20 amRNSAdditional Listing
24th Jan 20249:47 amRNSAdditional Listing
17th Jan 202412:44 pmRNSDirector/PDMR Shareholding
17th Jan 20249:44 amRNSAdditional Listing
16th Jan 20247:00 amRNSExperian Q3 FY24 trading update
12th Jan 20245:44 pmRNSFirst Interim Dividend
10th Jan 202410:55 amRNSAdditional Listing
3rd Jan 20249:02 amRNSAdditional Listing
29th Dec 202310:03 amRNSTotal Voting Rights
15th Dec 20239:32 amRNSElections for first interim dividend
13th Dec 20239:31 amRNSAdditional Listing
6th Dec 20239:14 amRNSAdditional Listing
30th Nov 202312:14 pmRNSTotal Voting Rights
29th Nov 20239:43 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.